Related Experiment Videos
The hygiene theory: fact or fiction?
Aziz Sheikh1, David P Strachan
1Division of Community Health Sciences: GP Section, University of Edinburgh, UK. aziz.sheikh@ed.ac.uk
Summary
The hygiene hypothesis suggests reduced early-life infections explain rising allergy rates. Evidence supports this, linking infections like H. pylori to lower allergy risk, though the exact mechanisms require further study.
Area of Science:
- Immunology
- Epidemiology
- Microbiology
Background:
- Rising prevalence of allergic diseases in industrialized nations.
- The hygiene hypothesis as a potential explanation for increased allergy rates.
- Review of current evidence supporting and refuting the hygiene hypothesis.
Purpose of the Study:
- To review recent evidence for and against the hygiene hypothesis.
- To explore the role of early-life exposures and microbial environments in allergy development.
- To examine the T-helper (Th)1/Th2 regulatory model in the context of allergic disorders.
Main Methods:
- Review of epidemiological studies on birth order and household size.
- Analysis of evidence linking specific infections (e.g., hepatitis A, H. pylori, geohelminths) to reduced atopy.
- Examination of cytokine profiles and probiotic effects on atopic dermatitis.
- Assessment of studies investigating the inverse relationship between Th1 and Th2 mediated disorders.
Main Results:
- Robust epidemiological data confirm birth order effects and reduced atopy risk in smaller, affluent households.
- Infections with hepatitis A, H. pylori, toxoplasma, and geohelminths are associated with decreased atopic manifestations.
- Evidence suggests infections modulate T-helper (Th)1/Th2 regulation, supported by cytokine studies and probiotic benefits.
- Conflicting results regarding the Th1/Th2 paradigm suggest potential oversimplification.
Conclusions:
- The hygiene hypothesis remains a plausible, though nonspecific, explanation for allergy prevalence variations.
- Further prospective studies are needed to identify specific protective infectious agents and critical exposure periods.
- Current clinical implications for managing atopic allergic disorders are limited.